Bloomberg BNA’s Patent Trademark & Copyright Law Daily™is the IP industry’s premier news service, offering objective, timely,and reliable daily news coverage and commentary from leading IP law...
March 24 — Bayer AG doesn't sell pain medicine under the brand name “Flanax” in the U.S. but can still bring false association and false advertising claims against a U.S. company that does, the U.S. Court of Appeals for the Fourth Circuit ruled March 23.
A plaintiff isn't required to hold valid trademark rights in the U.S. to bring those claims under the federal trademark statute, unlike with an infringement claim, the court said. It vacated a lower court's ruling that Bayer didn't have standing in the case.
The appeals court agreed with the Trademark Trial and Appeal board that Bayer can sue over use of the name “Flanax,” which is the name it uses for its naproxen sodium product sold in Mexico. The product is called “Aleve” in the U.S.
Bayer doesn't use the name “Flanax” here but has used it in Mexico since 1976.
Belmora LLC registered “Flanax” with the Patent and Trademark Office and marketed the product to the Mexican-American community.
Bayer sought cancellation of the registration, arguing that Belmora was inappropriately riding on its product's reputation. The marketing, for example, explicitly referred to Flanax being used for “many, many years in Mexico.” Belmora's packaging was also very similar to Mexican Flanax's packaging.
The TTAB ordered cancellation of the registration under Section 14(3) of the Lanham Trademark Act of 1946, 15 U.S.C. §1064(3) .
Belmora appealed the ruling to the U.S. District Court for the Eastern District of Virginia, which reversed the TTAB.
The court said that Bayer didn't have standing to oppose Belmora's use or registration of “Flanax” in the U.S. because it wasn't using the trademark here .
But the appeals court disagreed, drawing a distinction between trademark infringement claims under the Trademark Act and false association or false advertising claims.
Infringement claims under Section 32 of the Trademark Act, 15 U.S.C. §1114, require a plaintiff to show trademark rights—and use in commerce of a trademark—within the U.S.
But the court said that there is no such requirement for the false association and false advertising claims under Section 43(a) of the Trademark Act, 15 U.S.C. §1125(a).
The court concluded that Bayer could bring its false association and false advertising claims under Section 43(a) and could seek cancellation of the registration under Section 14(3), reversing the district court's ruling and remanding the matter back for further proceedings.
Judge G. Steven Agee wrote the court's ruling, joined by Judges Henry F. Floyd and Stephanie D. Thacker.
Pattishall, McAuliffe, Newbury, Hilliard & Geraldson LLP, Chicago, represented Bayer. Leason Ellis LLP, White Plains, N.Y., represented Belmora.
To contact the reporter on this story: Anandashankar Mazumdar in Washington at firstname.lastname@example.org
To contact the editor responsible for this story: Mike Wilczek in Washington at email@example.com
Text is available at: http://src.bna.com/dyA.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to firstname.lastname@example.org.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to email@example.com.
Put me on standing order
Notify me when new releases are available (no standing order will be created)